Hameln Pharma Plus Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HAMELN PHARMA PLUS, and what generic and branded alternatives to HAMELN PHARMA PLUS drugs are available?
HAMELN PHARMA PLUS has one approved drug.
Summary for Hameln Pharma Plus
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Hameln Pharma Plus
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hameln Pharma Plus | PENTETATE ZINC TRISODIUM | pentetate zinc trisodium | SOLUTION;INHALATION, INTRAVENOUS | 021751-001 | Aug 11, 2004 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
